Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 30.7.2025Herbacos Recordati s.r.o. (HEO-2)88690ACIFEIN (tbl 10 (blis.PVC/Al))31.7.2025O
 29.7.2025Teva B.V. (TEV-NL-4)8566EAtorvastatin Teva 30 mg (tbl flm 30x30 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8570EAtorvastatin Teva 30 mg (tbl flm 90x30 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8691EAtorvastatin Teva 80 mg (tbl flm 30x80 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8522EAtorvastatin Teva 20 mg (tbl flm 30x20 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8695EAtorvastatin Teva 80 mg (tbl flm 90x80 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8650EAtorvastatin Teva 60 mg (tbl flm 30x60 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)8607EAtorvastatin Teva 40 mg (tbl flm 30x40 mg (blis.PA/Al/PVC-Al))22.7.2025U
 29.7.2025Teva B.V. (TEV-NL-4)0329DMetformin Teva XR 500 mg (tbl plg 60x500 mg (blis.Al/PVC))15.10.2025R
 29.7.2025Teva B.V. (TEV-NL-4)7558AIsotretinoin Actavis 10 mg (cps mol 30x10 mg (blis.PVC/PVDC/Al))15.8.2025R
 29.7.2025Teva B.V. (TEV-NL-4)8608BAtomoxetine Actavis 60 mg (cps dur 28x60 mg (blis.PVC/PVDC/PVC/Al))24.7.2025O
 29.7.2025Teva B.V. (TEV-NL-4)1243ARaponer 8 mg (tbl plg 84x8 mg (blis.Al/Al))25.8.2025R
 29.7.2025GlaxoSmithKline Trading Services Limited (GAG-IRL-4)09961Ventolin (sir 1x150 ml (fľ.skl.jantár.))28.7.2025R
 29.7.2025GlaxoSmithKline Biologicals S.A. (GAG)45368Boostrix (sus iru 1x0,5 ml (striek.skl.napl. s ihlami/bez ihiel))28.7.2025R
 29.7.2025GlaxoSmithKline Trading Services Limited (GAG-IRL-3)87205Valtrex 500 mg (tbl flm 42x500 mg (blis.PVC/Al))18.7.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)